Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

328 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse.
Pentcheva-Hoang T, Egen JG, Wojnoonski K, Allison JP. Pentcheva-Hoang T, et al. Among authors: allison jp. Immunity. 2004 Sep;21(3):401-13. doi: 10.1016/j.immuni.2004.06.017. Immunity. 2004. PMID: 15357951
Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation.
Sullivan TJ, Letterio JJ, van Elsas A, Mamura M, van Amelsfort J, Sharpe S, Metzler B, Chambers CA, Allison JP. Sullivan TJ, et al. Among authors: allison jp. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2587-92. doi: 10.1073/pnas.051632398. Epub 2001 Feb 20. Proc Natl Acad Sci U S A. 2001. PMID: 11226283 Free PMC article.
Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade.
Hurwitz AA, Foster BA, Kwon ED, Truong T, Choi EM, Greenberg NM, Burg MB, Allison JP. Hurwitz AA, et al. Among authors: allison jp. Cancer Res. 2000 May 1;60(9):2444-8. Cancer Res. 2000. PMID: 10811122
In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance.
Sotomayor EM, Borrello I, Tubb E, Allison JP, Levitsky HI. Sotomayor EM, et al. Among authors: allison jp. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11476-81. doi: 10.1073/pnas.96.20.11476. Proc Natl Acad Sci U S A. 1999. PMID: 10500201 Free PMC article.
Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation.
van Elsas A, Hurwitz AA, Allison JP. van Elsas A, et al. Among authors: allison jp. J Exp Med. 1999 Aug 2;190(3):355-66. doi: 10.1084/jem.190.3.355. J Exp Med. 1999. PMID: 10430624 Free PMC article.
Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein.
Zhang Y, Allison JP. Zhang Y, et al. Among authors: allison jp. Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9273-8. doi: 10.1073/pnas.94.17.9273. Proc Natl Acad Sci U S A. 1997. PMID: 9256472 Free PMC article.
CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy.
Chambers CA, Kuhns MS, Egen JG, Allison JP. Chambers CA, et al. Among authors: allison jp. Annu Rev Immunol. 2001;19:565-94. doi: 10.1146/annurev.immunol.19.1.565. Annu Rev Immunol. 2001. PMID: 11244047 Review.
CTLA-4--the costimulatory molecule that doesn't: regulation of T-cell responses by inhibition.
Chambers CA, Allison JP. Chambers CA, et al. Among authors: allison jp. Cold Spring Harb Symp Quant Biol. 1999;64:303-12. doi: 10.1101/sqb.1999.64.303. Cold Spring Harb Symp Quant Biol. 1999. PMID: 11232300 Review. No abstract available.
Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells.
Kuhns MS, Epshteyn V, Sobel RA, Allison JP. Kuhns MS, et al. Among authors: allison jp. Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12711-6. doi: 10.1073/pnas.220423597. Proc Natl Acad Sci U S A. 2000. PMID: 11050166 Free PMC article.
Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses.
Chambers CA, Kuhns MS, Allison JP. Chambers CA, et al. Among authors: allison jp. Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8603-8. doi: 10.1073/pnas.96.15.8603. Proc Natl Acad Sci U S A. 1999. PMID: 10411922 Free PMC article.
328 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback